Click HereTherapeutic Options not on the QTdrugs List
Attention All Commercial Users of QTdrugs Technology
Commercial use or reproduction of the QTdrugs list or other copyrighted content from the CredibleMeds® website is prohibited unless licensed or authorized by AZCERT, Inc. Commercial use by a company's employee(s) or contractor(s) is defined in AZCERT's Terms of Use.
AZCERT's policy defines permissable, non-commercial use as any use by employees of government agencies, academic institutions, not-for-profit entities or self-employed healthcare providers.
Online orders for licenses can be placed here and quotes for licensing fees are available by contacting info@azcert.org.
Nelfinavir (Viracept®) and Ivabradine (Procoralan®, Coralan®, Corlentor®, Coraxan®, Ivabid®, Bradia®) have been added to the list of medicines with Conditional Risk of Torsades de Pointes (TdP).
Azithromycin has been associated with increased risk of death(1) and since June 2012 has been on the CredibleMeds list of QT-prolonging drugs that have “Known Risk of Torsades de Pointes (TdP).”
Research at AZCERT has documented the greater sensitivity of women to the effects of medicines that have effects on the heart and prolong the QT interval on the ECG, the influence of their menstrual cycle and the corresponding increase in…
Text for citing the use of the QTdrugs List or the CredibleMeds.org website:
Woosley RL, Heise CW , Gallo T, Woosley D and Romero KA, www.CredibleMeds.org, QTdrugs List, [Accession Date], AZCERT, Inc. 1457 E. Desert Garden Dr., Tucson, AZ 85718
Copyright: The CredibleMeds® website is intended for personal and professional use only. Its content is protected by U.S. Copyright. Unauthorized use for commercial purposes is prohibited.